Kevin Horgan is a seasoned physician scientist with a wealth of executive leadership experience in the development of both large and small molecules across diverse therapeutic areas, particularly focusing on immunology, inflammation, and immuno-oncology.

With a background in clinical development of novel therapies and diagnostics, Kevin holds a special expertise in areas such as immunology, inflammation, Alzheimer's disease translational medicine, proteomics, personalized medicine, and data science.

He pursued his education at Crescent College, Donhead, and earned a degree in Medicine & Physiology from the University College Cork.

Kevin's professional journey includes serving as a Board Member at Protypia Inc and holding advisory roles at various organizations such as Io Therapeutics and Emerald Logic.

He has held esteemed positions such as Chief Medical Officer and Executive Vice President at Seres Therapeutics, Global Medicine Leader and Vice President of Immuno-Oncology at Astra Zeneca, and Chief Medical Officer at Coronado Biosciences, among others.

Kevin also contributed to organizations like General Electric Healthcare, Centocor (Johnson and Johnson), Merck Research Laboratories, and held academic positions at UCLA and the National Cancer Institute.

His medical experience includes roles such as Resident at The Johns Hopkins Hospital and Senior House Officer in Medicine at Queen Elizabeth Hospital, Birmingham, UK.